Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

por Gulati, Swati, Luckhardt, Tracy R
Publicado 2020

Canine acquired pneumonia caused by Bordetella bronchiseptica

por Tatem, Luis Lantigua, Veale, Todd, Richardson, Christopher, Luckhardt, Tracy
Publicado 2023

A REMARKABLE RESPONSE TO ANGIOTENSIN II THERAPY IN SEVERE SARS-COV-2 INFECTION

por Goetz, Ryan, Joshi, Rutwij, Chiles, Joe, Scullin, Daniel, Wade, Raymond, Luckhardt, Tracy, Wells, James
Publicado 2020

Serpine 1 induces alveolar type II cell senescence through activating p53‐p21‐Rb pathway in fibrotic lung disease

por Jiang, Chunsun, Liu, Gang, Luckhardt, Tracy, Antony, Veena, Zhou, Yong, Carter, A. Brent, Thannickal, Victor J., Liu, Rui‐Ming
Publicado 2017

NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury

por Hecker, Louise, Vittal, Ragini, Jones, Tamara, Jagirdar, Rajesh, Luckhardt, Tracy R., Horowitz, Jeffrey C., Pennathur, Subramaniam, Martinez, Fernando J., Thannickal, Victor J.
Publicado 2009

Lung function trajectories in patients with idiopathic pulmonary fibrosis

por Neely, Megan L, Hellkamp, Anne S, Bender, Shaun, Todd, Jamie L, Liesching, Timothy, Luckhardt, Tracy R, Oldham, Justin M, Raj, Rishi, White, Eric S, Palmer, Scott M
Publicado 2023

Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients

por Kulkarni, Tejaswini, Yuan, Kaiyu, Tran-Nguyen, Thi K., Kim, Young-il, de Andrade, Joao A., Luckhardt, Tracy, Valentine, Vincent G., Kass, Daniel J., Duncan, Steven R.
Publicado 2019

TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis

por Luckhardt, Tracy R, Coomes, Stephanie M, Trujillo, Glenda, Stoolman, Joshua S, Vannella, Kevin M, Bhan, Urvashi, Wilke, Carol A, Moore, Thomas A, Toews, Galen B, Hogaboam, Cory, Moore, Bethany B
Publicado 2011

Evaluating the consistency with guideline recommendations for diagnosis and management of idiopathic pulmonary fibrosis in non-academic settings

por Luckhardt, Tracy R., Sonavane, Sushilkumar K., Crowe, D. Ralph, Kulkarni, Tejaswini, Acosta Lara, Maria del Pilar, Gulati, Swati, Il-Kim, Young, Ramachandran, Rekha, O’Beirne, Ronan, de Andrade, Joao A.
Publicado 2023

Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations

por Kulkarni, Tejaswini, Valentine, Vincent G., Fei, Fei, Tran-Nguyen, Thi K., Quesada-Arias, Luisa D., Mkorombindo, Takudzwa, Pham, Huy P., Simmons, Sierra C., Dsouza, Kevin G., Luckhardt, Tracy, Duncan, Steven R.
Publicado 2021

Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

por Ruan, Peifeng, Todd, Jamie L, Zhao, Hongyu, Liu, Yi, Vinisko, Richard, Soellner, Julia F., Schmid, Ramona, Kaner, Robert J., Luckhardt, Tracy R., Neely, Megan L., Noth, Imre, Porteous, Mary, Raj, Rishi, Safdar, Zeenat, Strek, Mary E, Hesslinger, Christian, Palmer, Scott M., Leonard, Thomas B., Salisbury, Margaret L.
Publicado 2023